tiprankstipranks
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (DE:2TZ)
FRANKFURT:2TZ
Germany Market
2TZ
Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S
RESEARCH TOOLSreports

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S (2TZ) Ratios

0 Followers

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. Class S Ratios

DE:2TZ's free cash flow for Q2 2026 was ¥0.72. For the 2026 fiscal year, DE:2TZ's free cash flow was decreased by ¥ and operating cash flow was ¥0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.38 1.59 2.35 2.03 2.17
Quick Ratio
 1.13 1.34 1.89 1.54 1.74
Cash Ratio
 0.54 0.23 1.04 0.66 0.86
Solvency Ratio
 0.21 0.49 0.81 0.31 0.27
Operating Cash Flow Ratio
 0.20 0.10 0.33 0.21 0.20
Short-Term Operating Cash Flow Coverage
 9.56 7.96 42.70 8.42 6.66
Net Current Asset Value
¥ 1.64B¥ 2.56B¥ 3.69B¥ 2.97B¥ 3.64B
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 <0.01 0.03 0.03
Debt-to-Equity Ratio
 0.02 <0.01 <0.01 0.05 0.04
Debt-to-Capital Ratio
 0.02 <0.01 <0.01 0.05 0.04
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.04 0.02
Financial Leverage Ratio
 1.77 1.65 1.37 1.55 1.56
Debt Service Coverage Ratio
 8.90 33.33 38.50 9.64 8.94
Interest Coverage Ratio
 90.95 271.71 63.86 30.60 95.44
Debt to Market Cap
 <0.01 <0.01 <0.01 0.03 0.04
Interest Debt Per Share
 0.14 0.09 0.09 0.47 0.35
Net Debt to EBITDA
 -2.23 -0.37 -1.06 -1.43 -2.37
Profitability Margins
Gross Profit Margin
74.46%74.02%48.18%44.01%39.93%
EBIT Margin
20.31%50.77%35.84%13.76%12.01%
EBITDA Margin
22.35%53.12%37.57%15.34%13.42%
Operating Profit Margin
18.33%50.63%35.13%13.34%11.88%
Pretax Profit Margin
20.60%50.59%35.29%13.32%11.88%
Net Profit Margin
17.96%43.34%30.51%12.00%10.45%
Continuous Operations Profit Margin
17.61%42.92%30.32%11.78%10.59%
Net Income Per EBT
87.19%85.67%86.45%90.08%87.92%
EBT Per EBIT
112.41%99.91%100.47%99.85%100.01%
Return on Assets (ROA)
8.05%18.23%20.70%9.65%8.48%
Return on Equity (ROE)
11.47%30.02%28.42%14.95%13.21%
Return on Capital Employed (ROCE)
14.36%34.66%32.28%15.68%14.36%
Return on Invested Capital (ROIC)
12.08%29.17%27.66%13.70%12.61%
Return on Tangible Assets
8.29%18.73%21.40%10.03%8.81%
Earnings Yield
3.19%11.62%18.48%8.67%14.38%
Efficiency Ratios
Receivables Turnover
 3.07 3.11 5.51 3.10 2.96
Payables Turnover
 5.19 5.86 13.31 4.09 3.52
Inventory Turnover
 1.08 1.13 2.94 2.94 3.47
Fixed Asset Turnover
 4.22 4.31 5.24 5.70 5.63
Asset Turnover
 0.45 0.42 0.68 0.80 0.81
Working Capital Turnover Ratio
 1.89 1.53 2.06 2.27 2.09
Cash Conversion Cycle
 385.02 378.76 162.70 152.69 124.97
Days of Sales Outstanding
 118.92 117.33 66.18 117.77 123.23
Days of Inventory Outstanding
 336.43 323.73 123.95 124.19 105.29
Days of Payables Outstanding
 70.33 62.31 27.43 89.27 103.55
Operating Cycle
 455.35 441.06 190.13 241.96 228.52
Cash Flow Ratios
Operating Cash Flow Per Share
 1.16 0.60 1.20 0.89 0.88
Free Cash Flow Per Share
 1.01 0.45 1.05 0.71 0.74
CapEx Per Share
 0.15 0.15 0.15 0.18 0.14
Free Cash Flow to Operating Cash Flow
 0.87 0.74 0.87 0.80 0.84
Dividend Paid and CapEx Coverage Ratio
 0.45 0.42 0.82 0.69 1.37
Capital Expenditure Coverage Ratio
 7.94 3.89 7.85 4.89 6.28
Operating Cash Flow Coverage Ratio
 9.06 7.37 33.93 2.11 2.63
Operating Cash Flow to Sales Ratio
 0.19 0.09 0.13 0.08 0.08
Free Cash Flow Yield
3.96%1.87%6.69%4.81%9.50%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 31.32 8.61 5.41 11.53 6.96
Price-to-Sales (P/S) Ratio
 4.17 3.73 1.65 1.38 0.73
Price-to-Book (P/B) Ratio
 4.48 2.58 1.54 1.72 0.92
Price-to-Free Cash Flow (P/FCF) Ratio
 25.28 53.57 14.95 20.78 10.53
Price-to-Operating Cash Flow Ratio
 29.85 39.79 13.05 16.53 8.85
Price-to-Earnings Growth (PEG) Ratio
 -0.41 -1.92 0.04 0.81 0.58
Price-to-Fair Value
 4.48 2.58 1.54 1.72 0.92
Enterprise Value Multiple
 16.43 6.66 3.33 7.60 3.04
Enterprise Value
 17.34B 17.39B 9.15B 9.58B 3.37B
EV to EBITDA
 16.43 6.66 3.33 7.60 3.04
EV to Sales
 3.67 3.54 1.25 1.17 0.41
EV to Free Cash Flow
 22.26 50.78 11.34 17.50 5.92
EV to Operating Cash Flow
 19.46 37.72 9.89 13.91 4.97
Tangible Book Value Per Share
 7.32 8.82 9.75 8.11 8.03
Shareholders’ Equity Per Share
 7.71 9.23 10.20 8.56 8.48
Tax and Other Ratios
Effective Tax Rate
 0.15 0.15 0.14 0.12 0.11
Revenue Per Share
 6.13 6.39 9.50 10.67 10.73
Net Income Per Share
 1.10 2.77 2.90 1.28 1.12
Tax Burden
 0.87 0.86 0.86 0.90 0.88
Interest Burden
 1.01 1.00 0.98 0.97 0.99
Research & Development to Revenue
 0.04 0.04 0.02 0.02 0.02
SG&A to Revenue
 0.33 0.36 0.24 0.22 0.25
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 <0.01
Income Quality
 1.05 0.22 0.42 0.71 0.78
Currency in CNY